160 related articles for article (PubMed ID: 36153805)
1. Loss of phospholipase Cγ1 suppresses hepatocellular carcinogenesis through blockade of STAT3-mediated cancer development.
Seo EB; Jang HJ; Kwon SH; Kwon YJ; Kim SK; Lee SH; Jeong AJ; Shin HM; Kim YN; Ma S; Kim H; Lee YH; Suh PG; Ye SK
Hepatol Commun; 2022 Nov; 6(11):3234-3246. PubMed ID: 36153805
[TBL] [Abstract][Full Text] [Related]
2. STAT3 activation in monocytes accelerates liver cancer progression.
Wu WY; Li J; Wu ZS; Zhang CL; Meng XL
BMC Cancer; 2011 Dec; 11():506. PubMed ID: 22136659
[TBL] [Abstract][Full Text] [Related]
3. DJ-1 promotes development of DEN-induced hepatocellular carcinoma and proliferation of liver cancer cells.
Qiu B; Wang J; Yu Y; Zhen C; Gu J; Liu W; Wen Y; Chen L; Gao Y; Xia Q; Kong X
Oncotarget; 2017 Jan; 8(5):8499-8511. PubMed ID: 28036277
[TBL] [Abstract][Full Text] [Related]
4. Lack of gp130 expression in hepatocytes attenuates tumor progression in the DEN model.
Hatting M; Spannbauer M; Peng J; Al Masaoudi M; Sellge G; Nevzorova YA; Gassler N; Liedtke C; Cubero FJ; Trautwein C
Cell Death Dis; 2015 Mar; 6(3):e1667. PubMed ID: 25741592
[TBL] [Abstract][Full Text] [Related]
5. HERC2 promotes inflammation-driven cancer stemness and immune evasion in hepatocellular carcinoma by activating STAT3 pathway.
Liu Y; Xu Q; Deng F; Zheng Z; Luo J; Wang P; Zhou J; Lu X; Zhang L; Chen Z; Zhang Q; Chen Q; Zuo D
J Exp Clin Cancer Res; 2023 Feb; 42(1):38. PubMed ID: 36721234
[TBL] [Abstract][Full Text] [Related]
6. Histone H1.2 promotes hepatocarcinogenesis by regulating signal transducer and activator of transcription 3 signaling.
Wang Q; Chen Y; Xie Y; Yang D; Sun Y; Yuan Y; Chen H; Zhang Y; Huang K; Zheng L
Cancer Sci; 2022 May; 113(5):1679-1692. PubMed ID: 35294987
[TBL] [Abstract][Full Text] [Related]
7. Metabolic pathway analyses identify proline biosynthesis pathway as a promoter of liver tumorigenesis.
Ding Z; Ericksen RE; Escande-Beillard N; Lee QY; Loh A; Denil S; Steckel M; Haegebarth A; Wai Ho TS; Chow P; Toh HC; Reversade B; Gruenewald S; Han W
J Hepatol; 2020 Apr; 72(4):725-735. PubMed ID: 31726117
[TBL] [Abstract][Full Text] [Related]
8. STAT3 and AKT signaling pathways mediate oncogenic role of NRSF in hepatocellular carcinoma.
Ma M; Zhou Y; Sun R; Shi J; Tan Y; Yang H; Zhang M; Shen R; Xu L; Wang Z; Fei J
Acta Biochim Biophys Sin (Shanghai); 2020 Oct; 52(10):1063-1070. PubMed ID: 32556117
[TBL] [Abstract][Full Text] [Related]
9. Gab2 mediates hepatocellular carcinogenesis by integrating multiple signaling pathways.
Cheng J; Zhong Y; Chen S; Sun Y; Huang L; Kang Y; Chen B; Chen G; Wang F; Tian Y; Liu W; Feng GS; Lu Z
FASEB J; 2017 Dec; 31(12):5530-5542. PubMed ID: 28842424
[TBL] [Abstract][Full Text] [Related]
10. Cross-talk between phospho-STAT3 and PLCγ1 plays a critical role in colorectal tumorigenesis.
Zhang P; Zhao Y; Zhu X; Sedwick D; Zhang X; Wang Z
Mol Cancer Res; 2011 Oct; 9(10):1418-28. PubMed ID: 21840932
[TBL] [Abstract][Full Text] [Related]
11. ZEB1 Transcriptionally Activates PHGDH to Facilitate Carcinogenesis and Progression of HCC.
Wang H; Lin F; Xu Z; Yu S; Li G; Liao S; Zhao W; Zhang F; Wang J; Wang S; Ouyang C; Zhang C; Xia H; Wu Y; Jiang B; Li Q
Cell Mol Gastroenterol Hepatol; 2023; 16(4):541-556. PubMed ID: 37331567
[TBL] [Abstract][Full Text] [Related]
12. STAT3 is Activated by CTGF-mediated Tumor-stroma Cross Talk to Promote HCC Progression.
Makino Y; Hikita H; Kato S; Sugiyama M; Shigekawa M; Sakamoto T; Sasaki Y; Murai K; Sakane S; Kodama T; Sakamori R; Kobayashi S; Eguchi H; Takemura N; Kokudo N; Yokoi H; Mukoyama M; Tatsumi T; Takehara T
Cell Mol Gastroenterol Hepatol; 2023; 15(1):99-119. PubMed ID: 36210625
[TBL] [Abstract][Full Text] [Related]
13. Phosphoinositide-specific phospholipase Cγ1 inhibition induces autophagy in human colon cancer and hepatocellular carcinoma cells.
Dai L; Chen X; Lu X; Wang F; Zhan Y; Song G; Hu T; Xia C; Zhang B
Sci Rep; 2017 Oct; 7(1):13912. PubMed ID: 29066806
[TBL] [Abstract][Full Text] [Related]
14. Constitutive Notch2 signaling induces hepatic tumors in mice.
Dill MT; Tornillo L; Fritzius T; Terracciano L; Semela D; Bettler B; Heim MH; Tchorz JS
Hepatology; 2013 Apr; 57(4):1607-19. PubMed ID: 23175466
[TBL] [Abstract][Full Text] [Related]
15. GNAS promotes inflammation-related hepatocellular carcinoma progression by promoting STAT3 activation.
Ding H; Zhang X; Su Y; Jia C; Dai C
Cell Mol Biol Lett; 2020; 25():8. PubMed ID: 32123532
[TBL] [Abstract][Full Text] [Related]
16. GSTZ1 deficiency promotes hepatocellular carcinoma proliferation via activation of the KEAP1/NRF2 pathway.
Li J; Wang Q; Yang Y; Lei C; Yang F; Liang L; Chen C; Xia J; Wang K; Tang N
J Exp Clin Cancer Res; 2019 Oct; 38(1):438. PubMed ID: 31666108
[TBL] [Abstract][Full Text] [Related]
17. SOCS2 protects against chemical-induced hepatocellular carcinoma progression by modulating inflammation and cell proliferation in the liver.
Cabrera-Galván JJ; Araujo E; de Mirecki-Garrido M; Pérez-Rodríguez D; Guerra B; Aranda-Tavío H; Guerra-Rodríguez M; Brito-Casillas Y; Melián C; Martínez-Martín MS; Fernández-Pérez L; Recio C
Biomed Pharmacother; 2023 Jan; 157():114060. PubMed ID: 36455458
[TBL] [Abstract][Full Text] [Related]
18. Dual role for inositol-requiring enzyme 1α in promoting the development of hepatocellular carcinoma during diet-induced obesity in mice.
Wu Y; Shan B; Dai J; Xia Z; Cai J; Chen T; Lv S; Feng Y; Zheng L; Wang Y; Liu J; Fang J; Xie D; Rui L; Liu J; Liu Y
Hepatology; 2018 Aug; 68(2):533-546. PubMed ID: 29506314
[TBL] [Abstract][Full Text] [Related]
19. Persistent mTORC1 activation via Depdc5 deletion results in spontaneous hepatocellular carcinoma but does not exacerbate carcinogen- and high-fat diet-induced hepatic carcinogenesis in mice.
Xu L; Yang C; Wang J; Li Z; Huang R; Ma H; Ma J; Wang Q; Xiong X
Biochem Biophys Res Commun; 2021 Nov; 578():142-149. PubMed ID: 34562654
[TBL] [Abstract][Full Text] [Related]
20. CCAAT/enhancer-binding protein homologous (CHOP) protein promotes carcinogenesis in the DEN-induced hepatocellular carcinoma model.
Scaiewicz V; Nahmias A; Chung RT; Mueller T; Tirosh B; Shibolet O
PLoS One; 2013; 8(12):e81065. PubMed ID: 24339898
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
